Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling

Identifieur interne : 001984 ( Main/Exploration ); précédent : 001983; suivant : 001985

Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling

Auteurs : Antonios Kolocouris [Grèce] ; Dimitrios Tataridis [Grèce] ; George Fytas [Grèce] ; Thomas Mavromoustakos [Grèce] ; George B. Foscolos [Grèce] ; Nicolas Kolocouris [Grèce] ; Erik De Clercq [Belgique]

Source :

RBID : ISTEX:9E203D1EE7819044016F00059E60F2B490E4BD85

Descripteurs français

English descriptors

Abstract

Abstract: The 2-(2-adamantyl)piperidines 13 and 15a-c were synthesized and evaluated for anti-influenza virus A and B activity. The parent N-H compound 13 was 3–4 times more active than amantadine and rimantadine against H2N2 influenza A. N-alkylation of 13 resulted in derivatives 15a-c that were devoid of biological activity. This dramatic reduction in biological activity may be attributed to the different conformational properties between N-H and N-alkyl piperidines, as deduced from the combination of computational chemistry and NMR spectroscopy.
2-(2-Adamantyl)piperidine 13 proved active against H2N2 influenza virus A. N-Alkylation resulted in inactive compounds 15a-c. This dramatic loss of activity could be attributed to comformational changes as indicated by computational analysis and NMR spectroscopy.gr1

Url:
DOI: 10.1016/S0960-894X(99)00631-9


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling</title>
<author>
<name sortKey="Kolocouris, Antonios" sort="Kolocouris, Antonios" uniqKey="Kolocouris A" first="Antonios" last="Kolocouris">Antonios Kolocouris</name>
</author>
<author>
<name sortKey="Tataridis, Dimitrios" sort="Tataridis, Dimitrios" uniqKey="Tataridis D" first="Dimitrios" last="Tataridis">Dimitrios Tataridis</name>
</author>
<author>
<name sortKey="Fytas, George" sort="Fytas, George" uniqKey="Fytas G" first="George" last="Fytas">George Fytas</name>
</author>
<author>
<name sortKey="Mavromoustakos, Thomas" sort="Mavromoustakos, Thomas" uniqKey="Mavromoustakos T" first="Thomas" last="Mavromoustakos">Thomas Mavromoustakos</name>
</author>
<author>
<name sortKey="Foscolos, George B" sort="Foscolos, George B" uniqKey="Foscolos G" first="George B." last="Foscolos">George B. Foscolos</name>
</author>
<author>
<name sortKey="Kolocouris, Nicolas" sort="Kolocouris, Nicolas" uniqKey="Kolocouris N" first="Nicolas" last="Kolocouris">Nicolas Kolocouris</name>
</author>
<author>
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:9E203D1EE7819044016F00059E60F2B490E4BD85</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1016/S0960-894X(99)00631-9</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-XKWTW4WL-N/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000097</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000097</idno>
<idno type="wicri:Area/Istex/Curation">000097</idno>
<idno type="wicri:Area/Istex/Checkpoint">000784</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000784</idno>
<idno type="wicri:doubleKey">0960-894X:1999:Kolocouris A:synthesis:of:adamantyl</idno>
<idno type="wicri:Area/Main/Merge">001A31</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:00-0080043</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000073</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000001</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000073</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000073</idno>
<idno type="wicri:doubleKey">0960-894X:1999:Kolocouris A:synthesis:of:adamantyl</idno>
<idno type="wicri:Area/Main/Merge">001A86</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10617092</idno>
<idno type="wicri:Area/PubMed/Corpus">000371</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000371</idno>
<idno type="wicri:Area/PubMed/Curation">000371</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000371</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000335</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000335</idno>
<idno type="wicri:Area/Ncbi/Merge">000013</idno>
<idno type="wicri:Area/Ncbi/Curation">000013</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000013</idno>
<idno type="wicri:doubleKey">0960-894X:1999:Kolocouris A:synthesis:of:adamantyl</idno>
<idno type="wicri:Area/Main/Merge">001A13</idno>
<idno type="wicri:Area/Main/Curation">001984</idno>
<idno type="wicri:Area/Main/Exploration">001984</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling</title>
<author>
<name sortKey="Kolocouris, Antonios" sort="Kolocouris, Antonios" uniqKey="Kolocouris A" first="Antonios" last="Kolocouris">Antonios Kolocouris</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>National Hellenic Research Foundation, Institute of Organic and Pharmaceutical Chemistry, Vas. Constantinou 48, 11635, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tataridis, Dimitrios" sort="Tataridis, Dimitrios" uniqKey="Tataridis D" first="Dimitrios" last="Tataridis">Dimitrios Tataridis</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, Division of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15771 Athens</wicri:regionArea>
<wicri:noRegion>GR-15771 Athens</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fytas, George" sort="Fytas, George" uniqKey="Fytas G" first="George" last="Fytas">George Fytas</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, Division of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15771 Athens</wicri:regionArea>
<wicri:noRegion>GR-15771 Athens</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Grèce</country>
</affiliation>
</author>
<author>
<name sortKey="Mavromoustakos, Thomas" sort="Mavromoustakos, Thomas" uniqKey="Mavromoustakos T" first="Thomas" last="Mavromoustakos">Thomas Mavromoustakos</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>National Hellenic Research Foundation, Institute of Organic and Pharmaceutical Chemistry, Vas. Constantinou 48, 11635, Athens</wicri:regionArea>
<placeName>
<settlement type="city">Athènes</settlement>
<region nuts="2" type="region">Attique (région)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Foscolos, George B" sort="Foscolos, George B" uniqKey="Foscolos G" first="George B." last="Foscolos">George B. Foscolos</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, Division of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15771 Athens</wicri:regionArea>
<wicri:noRegion>GR-15771 Athens</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kolocouris, Nicolas" sort="Kolocouris, Nicolas" uniqKey="Kolocouris N" first="Nicolas" last="Kolocouris">Nicolas Kolocouris</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Grèce</country>
<wicri:regionArea>Department of Pharmacy, Division of Pharmaceutical Chemistry, University of Athens, Panepistimioupoli-Zografou, GR-15771 Athens</wicri:regionArea>
<wicri:noRegion>GR-15771 Athens</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven</wicri:regionArea>
<orgName type="university">Katholieke Universiteit Leuven</orgName>
<placeName>
<settlement type="city">Louvain</settlement>
<region>Région flamande</region>
<region type="district" nuts="2">Province du Brabant flamand</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Bioorganic & Medicinal Chemistry Letters</title>
<title level="j" type="abbrev">BMCL</title>
<idno type="ISSN">0960-894X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1999">1999</date>
<biblScope unit="volume">9</biblScope>
<biblScope unit="issue">24</biblScope>
<biblScope unit="page" from="3465">3465</biblScope>
<biblScope unit="page" to="3470">3470</biblScope>
</imprint>
<idno type="ISSN">0960-894X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0960-894X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Antiviral</term>
<term>Antiviral Agents (chemical synthesis)</term>
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Cell Line</term>
<term>Chemical synthesis</term>
<term>Dogs</term>
<term>In vitro</term>
<term>Influenza A virus (drug effects)</term>
<term>Influenzavirus A</term>
<term>Influenzavirus B</term>
<term>Magnetic Resonance Spectroscopy</term>
<term>Modeling</term>
<term>Models, Molecular</term>
<term>Molecular model</term>
<term>Nitrogen heterocycle</term>
<term>Piperidines (chemical synthesis)</term>
<term>Piperidines (chemistry)</term>
<term>Piperidines (pharmacology)</term>
<term>Saturated compound</term>
<term>Structure activity relation</term>
<term>Tricyclic compound</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Antiviraux ()</term>
<term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (synthèse chimique)</term>
<term>Chiens</term>
<term>Lignée cellulaire</term>
<term>Modèles moléculaires</term>
<term>Pipéridines ()</term>
<term>Pipéridines (pharmacologie)</term>
<term>Pipéridines (synthèse chimique)</term>
<term>Spectroscopie par résonance magnétique</term>
<term>Virus de la grippe A ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en">
<term>Antiviral Agents</term>
<term>Piperidines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Antiviral Agents</term>
<term>Piperidines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antiviral Agents</term>
<term>Piperidines</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Influenza A virus</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antiviraux</term>
<term>Pipéridines</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr">
<term>Antiviraux</term>
<term>Pipéridines</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Line</term>
<term>Dogs</term>
<term>Magnetic Resonance Spectroscopy</term>
<term>Models, Molecular</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Adamantane dérivé</term>
<term>Animaux</term>
<term>Antiviral</term>
<term>Antiviraux</term>
<term>Chiens</term>
<term>Composé saturé</term>
<term>Composé tricyclique</term>
<term>Hétérocycle azote</term>
<term>In vitro</term>
<term>Influenzavirus A</term>
<term>Influenzavirus B</term>
<term>Lignée cellulaire</term>
<term>Modèle moléculaire</term>
<term>Modèles moléculaires</term>
<term>Modélisation</term>
<term>Pipéridine(2-[2-adamantyl])</term>
<term>Pipéridine(2-[2-adamantyl]-1-alkyl)</term>
<term>Pipéridines</term>
<term>Relation structure activité</term>
<term>Spectroscopie par résonance magnétique</term>
<term>Synthèse chimique</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Adamantane</term>
<term>Adamantane nucleus</term>
<term>Amantadine</term>
<term>Aminoadamantane heterocycles</term>
<term>Axial</term>
<term>Axial orientation</term>
<term>Biological activity</term>
<term>Bioorg</term>
<term>Chem</term>
<term>Clercq</term>
<term>Computational</term>
<term>Computational chemistry</term>
<term>Conformational</term>
<term>Conformational properties</term>
<term>Conformer</term>
<term>Conformers</term>
<term>Derivative</term>
<term>Energy conformers</term>
<term>Force field</term>
<term>Fytas</term>
<term>Heterocycle</term>
<term>Influenza</term>
<term>Influenza virus</term>
<term>Kolocouris</term>
<term>Lett</term>
<term>Parent piperidine</term>
<term>Pharmaceutical chemistry</term>
<term>Piperidine</term>
<term>Piperidine heterocycle</term>
<term>Piperidine heterocycles</term>
<term>Piperidines</term>
<term>Rimantadine</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: The 2-(2-adamantyl)piperidines 13 and 15a-c were synthesized and evaluated for anti-influenza virus A and B activity. The parent N-H compound 13 was 3–4 times more active than amantadine and rimantadine against H2N2 influenza A. N-alkylation of 13 resulted in derivatives 15a-c that were devoid of biological activity. This dramatic reduction in biological activity may be attributed to the different conformational properties between N-H and N-alkyl piperidines, as deduced from the combination of computational chemistry and NMR spectroscopy.</div>
<div type="abstract">2-(2-Adamantyl)piperidine 13 proved active against H2N2 influenza virus A. N-Alkylation resulted in inactive compounds 15a-c. This dramatic loss of activity could be attributed to comformational changes as indicated by computational analysis and NMR spectroscopy.gr1 </div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Belgique</li>
<li>Grèce</li>
</country>
<region>
<li>Attique (région)</li>
<li>Province du Brabant flamand</li>
<li>Région flamande</li>
</region>
<settlement>
<li>Athènes</li>
<li>Louvain</li>
</settlement>
<orgName>
<li>Katholieke Universiteit Leuven</li>
</orgName>
</list>
<tree>
<country name="Grèce">
<region name="Attique (région)">
<name sortKey="Kolocouris, Antonios" sort="Kolocouris, Antonios" uniqKey="Kolocouris A" first="Antonios" last="Kolocouris">Antonios Kolocouris</name>
</region>
<name sortKey="Foscolos, George B" sort="Foscolos, George B" uniqKey="Foscolos G" first="George B." last="Foscolos">George B. Foscolos</name>
<name sortKey="Fytas, George" sort="Fytas, George" uniqKey="Fytas G" first="George" last="Fytas">George Fytas</name>
<name sortKey="Fytas, George" sort="Fytas, George" uniqKey="Fytas G" first="George" last="Fytas">George Fytas</name>
<name sortKey="Kolocouris, Nicolas" sort="Kolocouris, Nicolas" uniqKey="Kolocouris N" first="Nicolas" last="Kolocouris">Nicolas Kolocouris</name>
<name sortKey="Mavromoustakos, Thomas" sort="Mavromoustakos, Thomas" uniqKey="Mavromoustakos T" first="Thomas" last="Mavromoustakos">Thomas Mavromoustakos</name>
<name sortKey="Tataridis, Dimitrios" sort="Tataridis, Dimitrios" uniqKey="Tataridis D" first="Dimitrios" last="Tataridis">Dimitrios Tataridis</name>
</country>
<country name="Belgique">
<region name="Région flamande">
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001984 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001984 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:9E203D1EE7819044016F00059E60F2B490E4BD85
   |texte=   Synthesis of 2-(2-adamantyl)piperidines and structure anti-influenza virus a activity relationship study using a combination of NMR spectroscopy and molecular modeling
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021